Delivering nitrogen preserved vaccines across Tanzania

August 6, 2012

Transporting a vaccine at -140 degrees Celsius on the difficult roads of Sub-Saharan Africa is problematic, but five students in life sciences have gone to Tanzania to attempt to find a solution.

The first effective vaccine against is currently undergoing in the US, and Africa, and may soon be distributed to the of Sub-Saharan Africa, especially where the disease in endemic. However, the problem of transporting this vaccine at the right temperature across the dirt roads and in these regions has still not been resolved.

Flavia Camponovo, a student of currently finishing her Bachelor’s Degree, is used to humanitarian aid missions. This year, while searching for a project related to her studies, she came across EssentialMed, a start up with the goal of developing medical materials adapted specifically for southern countries. Along with four other students, Damien Huzard, Naig Chenais, Martin Page and Frédéric Michoud, she is now in Tanzania attempting to find a solution.

Eventually, this project seeks to create an enterprise that deals with the logistics of delivering these vaccines in Tanzania, and that could, in the long term, aid with all the cryogenically preserved biological products in Tanzania and other African countries. The goal of this project, which is also headed by Sanaria, the producers of the vaccine, and the Swiss Tropical and Public Health Institute, directed by Marcel Tanner, is to come up with a simplified business plan at the end of the students’ stay. “This is truly an innovative concept that we could repeat if the experience provides conclusive results. I am curious to see their findings,” states Klaus Schonenberger, owner of EssentialMed.

Vaccines Transported in Nitrogen

The number of deaths caused by malaria in 2010 is estimated by the World Health Organization to be 655,000, with 91% of these deaths occurring in Africa. Mosquito nets and sprays only go so far, and they do not suffice to eradicate the disease. Moreover, the parasites responsible for the disease have become resistant to many of the anti-malaria medications currently in circulation.

The new vaccine is the first to be truly effective in fighting the parasite. 80% of people who receive the vaccine become immune to the parasite for 28 months following the vaccination. But, since the vaccine is made up of microorganisms, it must be handled carefully to ensure that it remains effective. To maintain the vaccine’s viability, it must be transported in liquid nitrogen, which is to say under -140° C. Therefore, the students will be confronted with two main problems: the efficiency of the distribution channels, making sure no time is lost in this delicate operation, and the specifics of the containers in which the vaccines are stored and transported.

“There already exist methods of cold transport in Africa, for products needed in artificial insemination of mammals and bovine vaccines for example. The goal of our project is to adapt these methods, especially to allow the transport of these products to remote villages,” explains Flavia Camponovo. The team has been there since July 19th, and has begun by exploring the existing distribution infrastructure and the various intermediaries to understand the specifics of this process and what changes must be made.

Tanzania seemingly has infrastructure that is already more vital and better organized than most of the Sub-Saharan countries. This includes central, regional and district storage facilities that furnish the shops of medical establishments in the more remote areas. Each stage of the distribution process must be taken into consideration, and the channels of distribution for these vaccines must be adapted to meet very particular requirements.

A Very Specific Type of Container

The distribution containers must be able to maintain a temperature of -140 Celsius for 30 to 35 days. The students have found an example in the prototypes developed by an American company that has already done research on the logistics, markets and prices for this type of transport. The conditions of transport are an additional constraint when considered in a country like Tanzania, where the essential network of roads is not paved. The containers must resist impact and inversion, and be small enough to be transported by motorcycle. They must also possess systems for security and temperature surveillance, making them exceptionally specialized and complex.

Creating a Business from the Logistics of Delivery

Flavia is motivated by humanitarian goals, and has already taught at schools in Africa and South America, but hopes that this time, her trip will be more geared toward engineering. After a fruitful meeting with Klaus Schonenberger, she has been enthusiastic about pursuing this project proposed by his company, EssentialMed, and returned one week later with four other students in life sciences. “This project allows us to gain personal, entrepreneurial and logistical experience. It could open up many possibilities for the distribution of the vaccine, even if we are not sure that our end result is the best possible solution,” she adds.

Explore further: Multiple malaria vaccine offers protection to people most at risk

Related Stories

Multiple malaria vaccine offers protection to people most at risk

October 26, 2011
A new malaria vaccine could be the first to tackle different forms of the disease and help those most vulnerable to infection, a study suggests.

A logistics approach to malaria in Africa

December 12, 2011
The problems of archaic logistics infrastructure, inefficient distribution channels and disruptive black markets must all be addressed urgently if Africa is to cope with the growing problem of malaria, according to a study ...

Modified vaccine shows promise in preventing malaria

September 26, 2011
Continuing a global effort to prevent malaria infections, Michigan State University researchers have created a new malaria vaccine – one that combines the use of a disabled cold virus with an immune system-stimulating ...

New development could increase flu vaccine supply

June 2, 2011
(Medical Xpress) -- Scientists from the U.S. Food and Drug Administration and the pharmaceutical company Novartis announced today in the journal Science Translational Medicine that they have developed a new adjuvant, or compound ...

Recommended for you

Study suggests ending opioid epidemic will take years

July 20, 2017
The question of how to stem the nation's opioid epidemic now has a major detailed response. A new study chaired by University of Virginia School of Law Professor Richard Bonnie provides extensive recommendations for curbing ...

Team-based model reduces prescription opioid use among patients with chronic pain by 40 percent

July 17, 2017
A new, team-based, primary care model is decreasing prescription opioid use among patients with chronic pain by 40 percent, according to a new study out of Boston Medical Center's Grayken Center for Addiction Medicine, which ...

Private clinics' peddling of unproven stem cell treatments is unsafe and unethical

July 7, 2017
Stem cell science is an area of medical research that continues to offer great promise. But as this week's paper in Science Translational Medicine highlights, a growing number of clinics around the globe, including in Australia, ...

Popular heartburn drugs linked to higher death risk

July 4, 2017
Popular heartburn drugs called proton pump inhibitors (PPIs) have been linked to a variety of health problems, including serious kidney damage, bone fractures and dementia. Now, a new study from Washington University School ...

Most reproductive-age women using opioids also use another substance

June 30, 2017
The majority of reproductive-age and pregnant women who use opioids for non-medical purposes also use at least one other substance, ranging from nicotine or alcohol to cocaine, according to a University of Pittsburgh Graduate ...

At-risk chronic pain patients taper opioids successfully with psychological tools

June 28, 2017
Psychological support and new coping skills are helping patients at high risk of developing chronic pain and long-term, high-dose opioid use taper their opioids and rebuild their lives with activities that are meaningful ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.